What We Do
Our vision is to transform patient lives by harnessing the untapped potential of amino acids for use as therapeutics and nutritional products in a large number of diseases and revolutionize drug discovery and development in the process.
At Axcella we use a nexus of comprehensive diagnostic approaches (including omics, genotyping, and imaging) and pathophysiologically based disease treatment and prevention. By addressing multiple dimensions of disease, we are taking the next evolutionary step in disease treatment through a multitargeted approach.
We are currently focused on developing therapeutics for a wide range of diseases including metabolic, muscle and neurological diseases. We are also developing innovative nutritional health products through Axcella’s wholly owned subsidiary, Acora.